Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1996 Nov;70(11):7498–7509. doi: 10.1128/jvi.70.11.7498-7509.1996

Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

N Mittereder 1, K L March 1, B C Trapnell 1
PMCID: PMC190817  PMID: 8892868

Abstract

Development of adenovirus vectors as potential therapeutic agents for multiple applications of in vivo human gene therapy has resulted in numerous preclinical and clinical studies. However, lack of standardization of the methods for quantifying the physical concentration and functionally active fraction of virions in these studies has often made comparison between various studies difficult or impossible. This study was therefore carried out to define the variables for quantification of the concentration of adenovirus vectors. The methods for evaluation of total virion concentration included electron microscopy and optical absorbance. The methods for evaluation of the concentration of functional virions included detection of gene transfer (transgene transfer and expression) and the plaque assay on 293 cells. Enumeration of total virion concentration by optical absorbance was found to be a precise procedure, but accuracy was dependent on physical disruption of the virion to eliminate artifacts from light scattering and also on a correct value for the extinction coefficient. Both biological assays for enumerating functional virions were highly dependent on the assay conditions and in particular the time of virion adsorption and adsorption volume. Under optimal conditions, the bioactivity of the vector, defined as the fraction of total virions which leads to detected target cell infection, was determined to be 0.10 in the plaque assay and 0.29 in the gene transfer assay. This difference is most likely due to the fact that detection by gene transfer requires only measurement of levels of transgene expression in the infected cell whereas plaque formation is dependent on a series of biological events of much greater complexity. These results show that the exact conditions for determination of infectious virion concentration and bioactivity of recombinant adenovirus vectors are critical and must be standardized for comparability. These observations may be very useful in comparison of data from different preclinical and clinical studies and may also have important implications for how adenovirus vectors can optimally be used in human gene therapy.

Full Text

The Full Text of this article is available as a PDF (488.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON A. C., VALENTINE R. C. Virus particle adsorption, III. Adsorption of viruses by cell monolayers and effects of some variables on adsorption. Biochim Biophys Acta. 1960 Jun 3;40:400–410. doi: 10.1016/0006-3002(60)91380-9. [DOI] [PubMed] [Google Scholar]
  2. ALLISON A. C., VALENTINE R. C. Virus particle adsorption. II. Adsorption of vaccinia and fowl plague viruses to cells in suspension. Biochim Biophys Acta. 1960 Jun 3;40:393–399. doi: 10.1016/0006-3002(60)91379-2. [DOI] [PubMed] [Google Scholar]
  3. Berkner K. L. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques. 1988 Jul-Aug;6(7):616–629. [PubMed] [Google Scholar]
  4. Crystal R. G., McElvaney N. G., Rosenfeld M. A., Chu C. S., Mastrangeli A., Hay J. G., Brody S. L., Jaffe H. A., Eissa N. T., Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet. 1994 Sep;8(1):42–51. doi: 10.1038/ng0994-42. [DOI] [PubMed] [Google Scholar]
  5. GREEN M., PINA M. Biochemical studies on adenovirus multiplication. IV. Isolation, purification, and chemical analysis of adenovirus. Virology. 1963 May;20:199–207. doi: 10.1016/0042-6822(63)90157-0. [DOI] [PubMed] [Google Scholar]
  6. Gene therapy for cystic fibrosis utilizing a replication deficient recombinant adenovirus vector to deliver the human cystic fibrosis transmembrane conductance regulator cDNA to the airways. A phase I study. Hum Gene Ther. 1994 Aug;5(8):1019–1057. doi: 10.1089/hum.1994.5.8-1019. [DOI] [PubMed] [Google Scholar]
  7. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977 Jul;36(1):59–74. doi: 10.1099/0022-1317-36-1-59. [DOI] [PubMed] [Google Scholar]
  8. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  9. Green M., Piña M., Kimes R. C. Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology. 1967 Mar;31(3):562–565. doi: 10.1016/0042-6822(67)90241-3. [DOI] [PubMed] [Google Scholar]
  10. Green M., Piña M., Kimes R., Wensink P. C., MacHattie L. A., Thomas C. A., Jr Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A. 1967 May;57(5):1302–1309. doi: 10.1073/pnas.57.5.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Knowles M. R., Hohneker K. W., Zhou Z., Olsen J. C., Noah T. L., Hu P. C., Leigh M. W., Engelhardt J. F., Edwards L. J., Jones K. R. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med. 1995 Sep 28;333(13):823–831. doi: 10.1056/NEJM199509283331302. [DOI] [PubMed] [Google Scholar]
  12. Lawrence W. C., Ginsberg H. S. Intracellular uncoating of type 5 adenovirus deoxyribonucleic acid. J Virol. 1967 Oct;1(5):851–867. doi: 10.1128/jvi.1.5.851-867.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lonberg-Holm K., Philipson L. Early events of virus-cell interaction in an adenovirus system. J Virol. 1969 Oct;4(4):323–338. doi: 10.1128/jvi.4.4.323-338.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maizel J. V., Jr, White D. O., Scharff M. D. The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology. 1968 Sep;36(1):115–125. doi: 10.1016/0042-6822(68)90121-9. [DOI] [PubMed] [Google Scholar]
  15. March K. L., Madison J. E., Trapnell B. C. Pharmacokinetics of adenoviral vector-mediated gene delivery to vascular smooth muscle cells: modulation by poloxamer 407 and implications for cardiovascular gene therapy. Hum Gene Ther. 1995 Jan;6(1):41–53. doi: 10.1089/hum.1995.6.1-41. [DOI] [PubMed] [Google Scholar]
  16. Mittereder N., Yei S., Bachurski C., Cuppoletti J., Whitsett J. A., Tolstoshev P., Trapnell B. C. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther. 1994 Jun;5(6):717–729. doi: 10.1089/hum.1994.5.6-717. [DOI] [PubMed] [Google Scholar]
  17. PHILIPSON L. Adenovirus assay by the fluorescent cell-counting procedure. Virology. 1961 Nov;15:263–268. doi: 10.1016/0042-6822(61)90357-9. [DOI] [PubMed] [Google Scholar]
  18. PORTERFIELD J. S., ALLISON A. C. Studies with poxviruses by an improved plaque technique. Virology. 1960 Feb;10:233–244. doi: 10.1016/0042-6822(60)90041-6. [DOI] [PubMed] [Google Scholar]
  19. Persson R., Svensson U., Everitt E. Virus receptor interaction in the adenovirus system. II. Capping and cooperative binding of virions on HeLa cells. J Virol. 1983 Jun;46(3):956–963. doi: 10.1128/jvi.46.3.956-963.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rosenfeld M. A., Collins F. S. Gene therapy for cystic fibrosis. Chest. 1996 Jan;109(1):241–252. doi: 10.1378/chest.109.1.241. [DOI] [PubMed] [Google Scholar]
  21. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992 Jan 10;68(1):143–155. doi: 10.1016/0092-8674(92)90213-v. [DOI] [PubMed] [Google Scholar]
  22. SCHWERDT C. E., FOGH J. The ratio of physical particles per infectious unit observed for poliomyelitis viruses. Virology. 1957 Aug;4(1):41–52. doi: 10.1016/0042-6822(57)90042-9. [DOI] [PubMed] [Google Scholar]
  23. Simon R. H., Engelhardt J. F., Yang Y., Zepeda M., Weber-Pendleton S., Grossman M., Wilson J. M. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther. 1993 Dec;4(6):771–780. doi: 10.1089/hum.1993.4.6-771. [DOI] [PubMed] [Google Scholar]
  24. Trapnell B. C., Gorziglia M. Gene therapy using adenoviral vectors. Curr Opin Biotechnol. 1994 Dec;5(6):617–625. doi: 10.1016/0958-1669(94)90084-1. [DOI] [PubMed] [Google Scholar]
  25. VALENTINE R. C., ALLISON A. C. Virus particle adsorption. I. Theory of adsorption and experiments on the attachment of particles to non-biological surfaces. Biochim Biophys Acta. 1959 Jul;34:10–23. doi: 10.1016/0006-3002(59)90228-8. [DOI] [PubMed] [Google Scholar]
  26. Wickham T. J., Granados R. R., Wood H. A., Hammer D. A., Shuler M. L. General analysis of receptor-mediated viral attachment to cell surfaces. Biophys J. 1990 Dec;58(6):1501–1516. doi: 10.1016/S0006-3495(90)82495-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wilson J. M., Engelhardt J. F., Grossman M., Simon R. H., Yang Y. Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial. Hum Gene Ther. 1994 Apr;5(4):501–519. doi: 10.1089/hum.1994.5.4-501. [DOI] [PubMed] [Google Scholar]
  28. Zabner J., Couture L. A., Gregory R. J., Graham S. M., Smith A. E., Welsh M. J. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell. 1993 Oct 22;75(2):207–216. doi: 10.1016/0092-8674(93)80063-k. [DOI] [PubMed] [Google Scholar]
  29. Zabner J., Petersen D. M., Puga A. P., Graham S. M., Couture L. A., Keyes L. D., Lukason M. J., St George J. A., Gregory R. J., Smith A. E. Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet. 1994 Jan;6(1):75–83. doi: 10.1038/ng0194-75. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES